You might say that Express Scripts has a bad case of the blues lately. Its stock plummeted in the weeks following a public statement by Anthem, the largest Blue Cross and Blue Shield plan, that it ...

ST. LOUIS -- Shares of Express Scripts Inc., among the nation's largest pharmacy benefit managers, extended their 52-week high on Friday, courtesy of its expectations of a better-than-expected first ...

Carl Icahn rattled the health care industry on Wednesday. Icahn, an activist investor, built a sizable stake in health insurer Cigna, the Wall Street Journal reported. Cigna is in the process of ...

Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, pharmacy benefit manager Express Scripts has earned a respected ...

FTC's July 2024 report makes unsubstantiated, false and biased claims about the PBM industry; fails to take into account the value that PBMs deliver to consumers and ...

Citron Research’s tweet suggesting President-elect Donald Trump begin his war on drug pricing with pharmacy benefit manager Express Scripts caused the company’s stock to fall as much as 9 percent ...

Total spending on health care in the United States is expected to climb from $3 trillion to over $4 trillion annually by the end of the decade, and while that may mean sales growth for a lot of health ...

Express Scripts director Dr. Woodrow Myers Jr. exercised stock options for 7,128 shares worth $30.83. Myers sold those shares for $64.66 on Sept. 4, which earned him $241,140 after paying to exercise ...

Valeant Pharmaceuticals Inc. sustained hits on several fronts on Thursday after CVS Health Corp. and Express Scripts dropped Philidor from their networks in a sign the fallout from the drugmaker's ...

Last year was blah for Express Scripts Holding Company shareholders. The giant pharmacy benefit manager's stock turned in 3% gain -- well below the 21% jump from the previous year. After just a few ...

NEW YORK (Reuters) - Express Scripts Inc. on Tuesday launched a $24.8 billion offer for Caremark Rx Inc. , the latest step in a high-stakes takeover battle after Caremark last week said it preferred a ...